Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$28.89
-6.1%
$30.76
$25.86
$39.08
$256.77M1.3826,243 shs65,205 shs
SNWV
SANUWAVE Health
$27.62
-1.3%
$31.20
$5.17
$39.50
$236.32M1.2531,796 shs24,826 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.84
+0.4%
$4.61
$4.01
$9.33
$79.59M1.3206,983 shs66,419 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.85
-3.0%
$4.10
$0.52
$5.92
$253.41M1.92749,825 shs395,955 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
+1.28%-0.84%-2.96%-13.54%-0.71%
SNWV
SANUWAVE Health
-2.03%-7.05%-1.79%+2,796,999,900.00%+2,796,999,900.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+2.77%+0.42%+1.69%-1.43%-20.98%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-0.50%-7.46%-11.38%-14.25%+82.11%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.6239 of 5 stars
3.51.00.00.01.41.70.6
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.7569 of 5 stars
3.64.00.00.02.50.01.3
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.5537 of 5 stars
3.32.00.00.00.61.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$49.5071.34% Upside
SNWV
SANUWAVE Health
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67141.05% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$5.5042.86% Upside

Current Analyst Ratings Breakdown

Latest SRTS, STIM, SMTI, and SNWV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/15/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$51.00 ➝ $53.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$46.00 ➝ $46.00
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $51.00
3/11/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $13.00
3/5/2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$5.00 ➝ $8.00
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$91.57M2.80N/AN/A$5.22 per share5.53
SNWV
SANUWAVE Health
$36.19M6.53N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$39.49M2.02$0.05 per share96.29$2.98 per share1.62
Neuronetics, Inc. stock logo
STIM
Neuronetics
$89.45M2.83N/AN/A$1.18 per share3.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$4.30M-$1.34N/AN/AN/A-10.71%-19.86%-10.91%8/11/2025 (Estimated)
SNWV
SANUWAVE Health
N/A-$4.56N/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1012.1021.04N/A15.90%12.60%11.38%8/14/2025 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$30.19M-$1.31N/AN/AN/A-50.09%-141.24%-32.77%8/11/2025 (Estimated)

Latest SRTS, STIM, SMTI, and SNWV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/14/2025Q1 2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.31-$0.41-$0.10-$0.41$23.48 million$23.43 million
5/9/2025Q1 2025
SNWV
SANUWAVE Health
N/A-$0.66N/A-$0.66N/A$9.34 million
5/6/2025Q1 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.13-$0.21-$0.08-$0.21$29.07 million$31.98 million
3/25/2025Q4 2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.19-$0.18+$0.01-$0.18$22.75 million$26.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
0.76
2.23
2.02
SNWV
SANUWAVE Health
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
10.52
7.89
Neuronetics, Inc. stock logo
STIM
Neuronetics
4.90
3.16
2.87

Institutional Ownership

CompanyInstitutional Ownership
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%
SNWV
SANUWAVE Health
42.53%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%

Insider Ownership

CompanyInsider Ownership
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
54.10%
SNWV
SANUWAVE Health
36.60%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
608.89 million4.01 millionNot Optionable
SNWV
SANUWAVE Health
408.56 millionN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.45 million14.85 millionOptionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18065.82 million27.37 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Sanara MedTech stock logo

Sanara MedTech NASDAQ:SMTI

$28.89 -1.89 (-6.14%)
Closing price 04:00 PM Eastern
Extended Trading
$28.90 +0.00 (+0.02%)
As of 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

SANUWAVE Health NASDAQ:SNWV

$27.62 -0.35 (-1.25%)
As of 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.84 +0.02 (+0.41%)
Closing price 04:00 PM Eastern
Extended Trading
$4.84 +0.00 (+0.10%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$3.85 -0.12 (-3.02%)
Closing price 04:00 PM Eastern
Extended Trading
$3.99 +0.14 (+3.64%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.